Clinical Trial Update: Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

View source ↗

Summary

This completed trial evaluated biomarker expression in individuals with diabetes mellitus type 1 or type 2 and in healthy controls over a one-year period.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED